Amit K. Sachdev
Executive Vice President and Chief Patient Officer
Mr. Sachdev joined Vertex in 2007 and is the Company’s Executive Vice President and Chief Patient Officer. In this role, Mr. Sachdev leads the company’s efforts to strengthen relationships with the CF community and build new ones globally with patients and advocates across the diseases Vertex is pursuing. He serves on the company’s Executive Committee and has held various leadership posts across the business over the past decade. In addition to Patient Advocacy and Engagement, he also oversees Government Affairs and Public Policy, and established Vertex’s first international commercial operations in 2010.
Prior to joining Vertex, Mr. Sachdev served as Executive Vice President at the Biotechnology Innovation Organization (BIO) and was Deputy Commissioner for Policy at the U.S. Food and Drug Administration (FDA) where he held several other senior executive appointments. Earlier in his career, Mr. Sachdev served as Majority Counsel to the Committee on Energy and Commerce in the U.S. House of Representatives and practiced law at the American Chemistry Council and also at the law firm Ropes & Gray.
Mr. Sachdev received a B.S. from Carnegie Mellon University and a J.D. from Emory University School of Law.